Sponsor or institution
Clinical trials and research at Velorum Therapeutics INC.
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $2.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
VEL-03: a new treatment approach for lung cancer and other solid tumors
A new drug candidate called VEL-03 aims to slow or stop the growth of non-small cell lung cancer and other solid tumors by targeting cancer cell metabolism.
-
Developing a new treatment for non-small cell lung cancer and other solid tumors
This study is testing a new treatment called VEL-03 for people with non-small cell lung cancer, which aims to help fight the cancer while being gentle on healthy cells, and it will be used alongside radiation and a common chemotherapy drug to see if it can improve results for patients.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.